64x Bio Launches LV Apex Suite, Expanding Its CellMap-Driven VectorSelect Platform Into Lentiviral Vector Production

Bio, a biotech company developing scalable solutions for the production of advanced therapies, today announced the launch of LV Apex Suite, a new product line designed to support high performance ...
Nasdaq

Mirus Bio Introduces the VirusGEN® GMP Product Line for Large-scale Therapeutic Adeno-associated Virus and Lentivirus Production

MADISON, Wis., Aug. 11, 2021 /PRNewswire/ -- Mirus Bio, an innovator in transfection technologies, today announces the launch of the TransIT® VirusGEN® GMP product line. This expansion to the existing ...
News Medical

Bio-Rad launches vericheck ddPCR replication competent lentivirus and replication competent AAV kits for cell and gene therapy production

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the recent launch of the Vericheck ddPCR™ Replication ...
Labroots

BalanCD HEK293 Viral Feed: Accelerating AAV and LV Production for Gene and Cell Therapy

Efficient viral vector production is essential for the cost-effective manufacture of cell and gene therapies. Many of the current production workflows are reliant on basal media in batch-mode, which ...
WCBD

Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System

Licensing of a proven stable producer system for lentiviral vector production represents a significant investment in next-generation technology for Genezen, offering its clients immediate access to ...